GHK-Cu + BPC-157 Stack

These two peptides attack tissue repair from completely different angles:

• BPC-157 is an acute repair accelerator. It promotes angiogenesis (new blood vessel formation), upregulates growth factor receptors (VEGF, FGF), and modulates nitric oxide to accelerate healing in the short term.
• GHK-Cu is a tissue remodeling agent. It influences over 4,000 genes, shifting their expression toward a younger, more regenerative pattern. It stimulates collagen III synthesis, decorin production, and has antioxidant effects.

BPC-157 handles the emergency repair. GHK-Cu ensures the repaired tissue is high-quality, well-organized, and resistant to re-injury. Together, they deliver both speed and quality of healing.

Both peptides are versatile in administration:

• BPC-157 — Subcutaneous injection near injury site for musculoskeletal issues. Oral for GI healing. Systemic subcutaneous for general health.
• GHK-Cu — Subcutaneous injection for systemic effects. Topical (cream or serum) for skin-specific rejuvenation. Can also be nebulized for lung tissue research.

For comprehensive healing, injectable forms of both are preferred. For skin rejuvenation specifically, GHK-Cu topical + BPC-157 injectable is a popular combination.

These peptides can be injected at the same time but should not be mixed in the same syringe due to different stability profiles (copper peptide interaction concerns). Protocol duration: 4–12 weeks depending on goals.

Weeks 1–2: BPC-157 begins accelerating localized repair. Pain and inflammation at injury sites decrease. GHK-Cu starts activating regenerative gene expression—effects not yet visible.

Weeks 2–6: Tissue remodeling accelerates. Skin quality improves (if using topical GHK-Cu)—fine lines soften, elasticity increases, tone evens out. Injury healing progresses faster than baseline.

Weeks 6–12: Full regenerative effects. Collagen density improves measurably. Chronic wounds or injuries show significant structural repair. Skin appears visibly younger with improved thickness and hydration.

Both peptides have exceptional safety profiles. GHK-Cu is a naturally occurring human peptide present in blood plasma, saliva, and urine—the body recognizes it. BPC-157 is derived from human gastric juice proteins. Side effects are rare and typically limited to mild injection-site irritation.

Precautions: GHK-Cu's copper component means individuals with Wilson's disease or copper sensitivity should avoid it. As with all healing peptides, avoid during active malignancy. If using topical GHK-Cu, patch test first for skin sensitivity.

GHK-Cu requires careful handling—the copper bond is sensitive to degradation. Ascension Peptides ensures proper manufacturing and storage:

• 99%+ purity for both GHK-Cu and BPC-157
• Proper lyophilization preserving the copper-peptide bond
• Third-party COAs verifying compound identity and purity

For a stack that depends on precise molecular structure, sourcing from Ascension Peptides is essential.